1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZFHX2 CTRPv2 pan-cancer AAC 0.17 9e-07
mRNA PROX1 CTRPv2 pan-cancer AAC 0.16 9e-07
mRNA VAMP2 CTRPv2 pan-cancer AAC 0.16 9e-07
mRNA CPT1B CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA NCOR1 CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA WDR6 CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA ZNF71 CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA KMT2B CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA U2AF2 CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA RP11-106M3.2 CTRPv2 pan-cancer AAC -0.16 1e-06
Download CSV